Erythropoietin Stimulating Agents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
The erythropoietin stimulating agents (ESAs) market was valued at approximately USD 8,223 million in 2020 and is expected to witness a revenue of USD 13,436 million in 2026, with a CAGR of 8.6% over the forecast period. According to a research study published in the American Journal of Kidney Disease, 2020, among the patients with COVID-19, with or without Acute Kidney Injury(AKI) and anemia,...
0 Comments 0 Shares
Sponsored